Possibly: Depending on the type of cancer, anti-angiogenesis may be used. For example, with some primary brain cancers, Avastin (bevacizumab) is an angiogenesis inhibitor that has reached fda approval status. There have been some other cancers where it was thought to have benefit initially, but then was shown not to be efficacious.
Answered 6/24/2014
4.7k views
For certain cancers: Anti-angiogenic therapies are used in certain malignancies. Whether or not these agents are used in the treatment of a given cancer is based on preclinical and clinical data. Some solid tumors seem to respond, while others devise a way to to become quickly resistant. There are many drugs of this class that target different pathways, and many clinical trials are currently being performed.
Answered 10/4/2016
4.7k views
Yes: Angiogenesis inhibition is probably the fourth most important field of cancer treatment after radiation, chemotherapy and surgery. See, for example, treatment with Erbitux and temodar (temozolomide).
Answered 4/3/2016
4.7k views
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
3 doctors weighed in across 3 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question